ZTS
Zoetis Inc.
Zoetis Inc. (ZTS) has 8 SEC Form 4 filings (11 transaction rows) in the rolling window, disclosed by 3 distinct insiders. Most recent filing: Jun 11, 2026.
Insiders have net bought $886K over the trailing 6 months.
- Industry:Drug Manufacturers - General
- CEO:Kristin C. Peck
- Employees:13,800
- HQ:Parsippany, NJ, US
- IPO:2013-02-01
Insider Buying
$886K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Unique Insiders
3
in the rolling window
Market Cap
$32.5B
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
DAMELIO FRANK AFirst filing | Director | Purchase | 6,650 | $501K | May 13 | SEC ↗ |
Bisaro PaulFirst filing | Director | Purchase | 2,000 | $152K | May 13 | SEC ↗ |
MCCALLISTER MICHAEL BFirst filing | Director | Purchase | 3,000 | $233K | May 12 | SEC ↗ |
Congress trading ZTS
See timeline →- RRep. Byron DonaldsPurchase$1,001 - $15,0002026-06-09
- RRep. Byron DonaldsPurchase$1,001 - $15,0002026-06-09
- RRep. Charles J. "Chuck" FleischmannPurchase$15,001 - $50,0002026-06-09
- DRep. Gilbert CisnerosPurchase$1,001 - $15,0002026-06-16
- DRep. Ro KhannaPurchase$1,001 - $15,0002026-05-01
STOCK Act disclosures are filed up to 45 days after the trade. Amount is a disclosed range, not an exact figure.
Related companies
Zoetis Inc. is in the Healthcare sector.